Targeted Organs/Cells
DMG-PEG2000-ANG (DMG-PEG2000-Mal-Cys-TFFYGGSRGKRNNFKTEEY) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an ANG (Angiopep-2) (HY-P2341) peptide as a terminal targeting/functional ligand. DMG-PEG2000-ANG can be used in research such as brain-targeted drug delivery.
DSG-PEG2000-ANG (DSG-PEG2000-Mal-Cys-TFFYGGSRGKRNNFKTEEY) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an ANG (Angiopep-2) (HY-P2341) peptide as a terminal targeting/functional ligand. DSG-PEG2000-ANG can be used in research such as brain-targeted drug delivery.
DSG-PEG2000-MTP (DSG-PEG2000-Mal-Cys-ASSLNIA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an MTP (HY-P10643) peptide as a terminal targeting/functional ligand. DSG-PEG2000-MTP can be used in research on muscle-targeted drug delivery and muscle tissue gene delivery.
DMG-PEG2000-YIGSR (DMG-PEG2000-Mal-Cys-YIGSR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a YIGSR (HY-P0132) peptide as a terminal targeting/functional ligand. DMG-PEG2000-YIGSR can be used in research such as tumor-targeted drug delivery.
DMG-PEG2000-TAASGVRSMH (DMG-PEG2000-Mal-Cys-TAASGVRSMH) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and the TAASGVRSMH (HY-P10989) peptide as a terminal targeting/functional ligand. DMG-PEG2000-TAASGVRSMH can be used in research on tumor-targeted drug delivery, among other applications.
DSG-PEG2000-CREKA (DSG-PEG2000-Mal-Cys-CREKA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CREKA (HY-P10709) peptide as a terminal targeting/functional ligand. DSG-PEG2000-CREKA can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.
DMG-PEG2000-KTP (DMG-PEG2000-Mal-Cys-KKEEEKKEEEKKEEEK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a KTP ((KKEEE)3K) (HY-P11452) peptide as a terminal targeting/functional ligand. DMG-PEG2000-KTP can be used in studies of renal targeted drug delivery.
DMG-PEG2000-A7R (DMG-PEG2000-Mal-Cys-ATWLPPR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an A7R (HY-P1663) peptide as a terminal targeting/functional ligand. DMG-PEG2000-A7R can be used in research such as tumor angiogenesis-targeted drug delivery.
DSG-PEG2000-BR2 (DSG-PEG2000-Mal-Cys-RAGLQFPVGRLLRRLLR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a BR2 peptide as a terminal targeting/functional ligand. DSG-PEG2000-BR2 can be used in research on targeted drug delivery for breast cancer.
DSG-PEG2000-SP94 (DSG-PEG2000-Mal-Cys-SP94) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and an SP94 (HY-P11050A) peptide as a terminal targeting/functional ligand. DSG-PEG2000-SP94 can be used in research on targeted drug delivery for hepatocellular carcinoma.
DMG-PEG2000-THRPPMWSPVWP (DMG-PEG2000-Mal-Cys-THRPPMWSPVWP) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dipalmitoyl-sn-glycerol-3-phosphoethanolamine (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a TfR-T12 (THRPPMWSPVWP) (HY-P2297) peptide as a terminal targeting/functional ligand. DMG-PEG2000-THRPPMWSPVWP can be used for brain-targeted drug delivery and the construction of drug delivery systems for central nervous system diseases.
DMG-PEG2000-GALA (DMG-PEG2000-Mal-Cys-WEAALAEALAEALAEHLAEALAEALEALAA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a GALA (HY-P5423) peptide as a terminal targeting/functional ligand. DMG-PEG2000-GALA can be used for pH-responsive drug delivery, endosome escape and cytoplasmic drug release, and cytoplasmic delivery of nucleic acids (siRNA/mRNA).
DMG-PEG2000-K237 (DMG-PEG2000-Mal-Cys-HTMYYHHYQHHL) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a polyethylene glycol (PEG) spacer arm with a molecular weight of 2000 Da, and a K237 peptide as a terminal targeting/functional ligand. DMG-PEG2000-K237 can be used in research on tumor-targeted drug delivery.
DMG-PEG2000-CGKRK (DMG-PEG2000-Mal-Cys-CGKRK) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CGKRK peptide as a terminal targeting/functional ligand. DMG-PEG2000-CGKRK can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.
DSG-PEG2000-THRPPMWSPVWP (DSG-PEG2000-Mal-Cys-THRPPMWSPVWP) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a TfR-T12 (THRPPMWSPVWP) (HY-P2297) peptide as a terminal targeting/functional ligand. DSG-PEG2000-THRPPMWSPVWP can be used for brain-targeted drug delivery and the construction of drug delivery systems for central nervous system diseases.
DSG-PEG2000-NGR (DSG-PEG2000-Mal-Cys-NGR) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an NGR (HY-P1043) peptide as a terminal targeting/functional ligand. DSG-PEG2000-NGR can be used for tumor angiogenesis-targeted drug delivery.
DSG-PEG2000-Asp6 (DSG-PEG2000-Mal-Cys-DDDDDD) is a functionalized PEGylated phospholipid conjugate composed of three modular components: distearoylglycerol (DSG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and an Asp6 peptide as a terminal targeting/functional ligand. DSG-PEG2000-Asp6 can be used in research such as bone-targeted drug delivery.
DMG-PEG2000-GRGDS (DMG-PEG2000-Mal-Cys-GRGDS) is a functionalized PEGylated phospholipid conjugate composed of three modular components: 1,2-dispalmitoyl-sn-glycerol-3-phosphoethanolamine (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a Gly-Arg-Gly-Asp-Ser (GRGDS) (HY-P0295) peptide as a terminal targeting/functional ligand. DMG-PEG2000-GRGDS can be used in research on tumor-targeted drug delivery.
DMG-PEG2000-CRPPR is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CRPPR (HY-P10641A) peptide as a terminal targeting/functional ligand. DMG-PEG2000-CRPPR can be used in studies of cardiac-targeted drug delivery.
DMG-PEG2000-CREKA (DMG-PEG2000-Mal-Cys-CREKA) is a functionalized PEGylated phospholipid conjugate composed of three modular components: dimyristoylglycerol (DMG) as a lipid anchoring group, a 2000 Da polyethylene glycol (PEG) spacer arm, and a CREKA (HY-P10709) peptide as a terminal targeting/functional ligand. DMG-PEG2000-CREKA can be used in research on tumor angiogenesis-targeted drug delivery, among other applications.
